QDDresearch

Walmart Inc. WMT

Consumer StaplesFood & Drug RetailingUnited States of America

Last close 123.51 USD on Nov 1, 2026, +11.6% year to date

Quant rating

Quant rating B Rank 24 of 124 in Consumer Staples
  1. Growth B 21 of 124
  2. Valuation D 110 of 124
  3. Quality A 15 of 124
  4. Revisions B 39 of 124
  5. Momentum A 18 of 124

Wall Street consensus Buy (1.84)Average target 127.52 USD +3.2%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Growth and profitability fiscal year ends January 31

Growth and profitability by fiscal year
202620252024202320225Y avg
Revenue (mil)713,163680,985648,125611,289572,754–
Revenue growth4.7%5.1%6.0%6.7%2.4%5.0%
EPS (basic, normalized)2.642.512.222.102.15–
EPS growth5.2%13.2%5.7%−2.6%––
Gross margin24.9%24.9%24.4%24.1%25.1%24.7%
Net margin3.1%2.9%2.4%1.9%2.4%2.5%
ROE23.0%22.2%19.3%14.6%16.7%19.2%
Balance sheet, last quarter
Cash & short-term investments (mil)11,529
Current ratio0.77x
Long-term debt (mil)42,414
Net debt (mil)52,275
Total equity (mil)98,238
Net debt / equity0.53x
Net debt / EBITDA1.16x

Estimates and valuation

Consensus estimates and implied multiples
Sales (mil)EBITDA (mil)EPS
Fiscal yearMean est.GrowthEV/SalesMean est.GrowthEV/EBITDAMean est.GrowthP/E
2026 actual 713,163+4.7%1.4x 45,185+6.5%22.8x 2.64+5.2%46.8x
2027 752,893+5.6%1.4x 49,361+9.2%20.9x 2.88+9.2%42.9x
2028 785,571+4.3%1.3x 53,513+8.4%19.3x 3.22+11.9%38.3x
2029 822,646+4.7%1.3x 58,180+8.7%17.7x 3.62+12.3%34.1x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
SalesEPS
Fiscal yearEstimate (mil)1M3M6MEstimate1M3M6M
2027752,8930.0%+0.1%+0.6%2.880.0%−0.7%−1.0%
2028785,5710.0%−0.2%+0.4%3.220.0%−1.6%−1.4%
2029822,6460.0%−0.1%+0.5%3.62+0.2%−1.4%−2.6%

Earnings surprises EPS beat in 4 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter endedApr 2024Jul 2024Oct 2024Jan 2025Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Sales reported (mil)161,508169,335169,588180,554165,609177,402179,496190,656177,751187,937
Sales mean (mil)159,502168,533167,718180,010165,929176,163177,429190,425174,982186,769
Surprise+1.3%+0.5%+1.1%+0.3%−0.2%+0.7%+1.2%+0.1%+1.6%+0.6%
EPS reported0.600.670.580.660.610.680.620.740.660.81
EPS mean0.520.650.530.640.580.740.600.730.660.74
Surprise+14.6%+3.8%+8.9%+2.6%+5.9%−8.3%+3.2%+1.9%+0.4%+9.3%

Peer comparison Food & Drug Retailing

Peers in the same industry group, by market capitalization
CompanyMarket capNet debt/EBITDANet marginP/BFY1 P/EFY2 P/EFY1 EV/EBITDAFY2 EV/EBITDA
WMT Walmart Inc.979.9B1.16x3.1%9.99x42.9x38.3x20.9x19.3x
SYY Sysco Corporation40.8B2.67x2.1%14.88x16.4x15.4x10.9x10.4x
KR Kroger Co39.4B1.86x0.7%6.81x12.9x12.2x6.7x6.6x
CASY Caseys General Stores Inc25.1B1.29x4.1%6.14x31.8x29.0x16.6x15.3x
USFD US Foods Holding Corp.22.4B2.77x1.7%5.24x21.7x18.7x13.2x12.0x
PFGC Performance Food Group Company15.6B3.48x0.5%3.16x17.5x14.9x10.1x9.2x
Mean2.20x2.0%7.70x23.9x21.4x13.1x12.2x
Median2.27x1.9%6.48x19.6x17.0x12.0x11.2x

Technical analysis

  • 1M+13.6%
  • 3M+9.5%
  • 1Y+20.7%
  • 3Y+137.2%

Financial statements in millions of USD

Income statement, Walmart Inc., fiscal years, most recent first
202620252024202320222021
Total revenue713,163680,985648,125611,289572,754559,151
Cost of revenue535,395511,753490,142463,721429,000420,315
Gross profit177,768169,232157,983147,568143,754138,836
Selling, general & administrative expenses147,943139,884130,971123,040115,312111,888
Research & development––––––
Interest expense (income), operating––––––
Unusual expense (income)––04,1005,71012,800
Other operating expenses000000
Operating income29,82529,34827,01220,42822,73214,148
Net interest income (expense)−331−1,845−4,737−2,974−4,2366,506
Gain (loss) on sale of assets––––––
Other non-operating income (expense)−25.0−1,194−427−438200−90.0
Net income before taxes29,46926,30921,84817,01618,69620,564
Provision for taxes7,1996,1525,5785,7244,7566,858
Minority interest−377−721−759388−267−196
Equity in affiliates––––––
U.S. GAAP adjustment––––––
Net income before extraordinary items21,89319,43615,51111,68013,67313,510
Extraordinary items––––––
Net income21,89319,43615,51111,68013,67313,510
EBIT, normalized29,82529,34827,01224,52828,44226,948
EBITDA, normalized44,02842,32138,86535,47339,14238,148
Basic EPS, normalized2.642.512.222.102.15–

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.